Literature DB >> 16739311

SMAD4/DPC4 expression and prognosis in human colorectal cancer.

Martin Isaksson-Mettävainio1, Richard Palmqvist, Johan Forssell, Roger Stenling, Ake Oberg.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies in Western countries. One major event during CRC development is loss of genetic material on chromosome 18, on which the smad4/dpc4 gene is located. SMAD4 is an important mediator of intracellular signaling in the TGF-beta pathway. The functional inactivation of SMAD4 has been reported to occur in CRC. MATERIALS AND
METHOD: The protein expression of SMAD4 was evaluated immunohistochemically in 86 formalin-fixed and paraffin-embedded CRC samples. The results were related to clinicopathological variables including survival.
RESULTS: The loss of nuclear SMAD4 protein expression was observed in 9.3% of the investigated CRCs and was correlated to poor prognosis in univariate Kaplan-Meier (p=0.034) as well as in multivariate Cox-regression (p=0.028) analyses.
CONCLUSION: The loss of nuclear SMAD4 protein expression occurs in a subset of CRC and is associated with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739311

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.

Authors:  Xi Ai; Yanhui Wu; Wei Zhang; Zhanguo Zhang; Guannan Jin; Jianping Zhao; Jingjing Yu; Youzhi Lin; Wanguang Zhang; Huifang Liang; Pran K Datta; Mingzhi Zhang; Bixiang Zhang; Xiaoping Chen
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

2.  Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.

Authors:  Ahmad Alkhasawneh; Lizette Vila Duckworth; Thomas J George; Neelam V Desai; Alex J Sommerfeld; Xiaomin Lu; Tania Zuluaga Toro
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 3.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.

Authors:  Tanner J Freeman; J Joshua Smith; Xi Chen; M Kay Washington; Joseph T Roland; Anna L Means; Steven A Eschrich; Timothy J Yeatman; Natasha G Deane; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2011-11-22       Impact factor: 22.682

5.  Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Roger K Wolff; Bette J Caan
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

6.  Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.

Authors:  Maya Gulubova; Irena Manolova; Julian Ananiev; Alexander Julianov; Yovcho Yovchev; Katya Peeva
Journal:  Int J Colorectal Dis       Date:  2010-02-18       Impact factor: 2.571

7.  Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.

Authors:  Wei Shen; Guo-Qing Tao; De-Chun Li; Xing-Guo Zhu; Xia Bai; Bing Cai
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  The role of SMAD4 in early-onset colorectal cancer.

Authors:  S G Royce; K Alsop; A Haydon; L Mead; L D Smith; A A Tesoriero; G G Giles; M A Jenkins; J L Hopper; M C Southey
Journal:  Colorectal Dis       Date:  2009-01-27       Impact factor: 3.788

Review 9.  Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy.

Authors:  Ganesan Ramamoorthi; Nageswaran Sivalingam
Journal:  Tumour Biol       Date:  2014-03-26

Review 10.  Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.

Authors:  Sabine Tejpar; Monica Bertagnolli; Fred Bosman; Heinz-Joseph Lenz; Levi Garraway; Frederic Waldman; Robert Warren; Andrea Bild; Denise Collins-Brennan; Hejin Hahn; D Paul Harkin; Richard Kennedy; Mohammad Ilyas; Hans Morreau; Vitali Proutski; Charles Swanton; Ian Tomlinson; Mauro Delorenzi; Roberto Fiocca; Eric Van Cutsem; Arnaud Roth
Journal:  Oncologist       Date:  2010-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.